Table 4.
a, b, c: Correlations between clinical parameters and microbiological and biochemical data
| Correlation between | Group | r | p* | n |
|---|---|---|---|---|
| (a) During the whole study (from W0 to W10) | ||||
| Overall clinical score for dandruff and histamine | Treated | 0.42028 | 0.0149 | 33 |
| Overall clinical score for dandruff and log M. restricta | Treated | 0.38194 | 0.0310 | 32 |
| Erythema and IL-1RA/IL-1α | Treated | 0.63538 | 0.0035 | 19 |
| Erythema and histamine | Treated | 0.38470 | 0.0271 | 33 |
| Erythema and PLK | Treated | 0.76376 | 0.0274 | 8 |
| Global efficacy SGA and histamine | Treated | −0.37528 | 0.0314 | 33 |
| Global efficacy SGA and log Malassezia total | Control | −0.38696 | 0.0346 | 30 |
| Correlation between | r | p* | n | |
|---|---|---|---|---|
| (b) During the intensive treatment phase (from W0 to W2) | ||||
| Overall clinical score for dandruff and IL-1RA/IL-1α | 0.40287 | 0.0055 | 46 | |
| Global efficacy SGA and IL-1RA/IL-1α | −0.35780 | 0.0146 | 46 | |
| Correlation between | Group | r | p* | n |
|---|---|---|---|---|
| (c) During the maintenance phase (from W2 to W10) | ||||
| Overall clinical score for dandruff and log M. globosa | Treated | 0.35862 | 0.0438 | 32 |
| Global efficacy SGA and histamine | Treated | −0.36098 | 0.0390 | 33 |
| Overall clinical score for dandruff and IL-1RA/IL-1α | Control | 0.61709 | 0.0083 | 17 |
| Itching and IL-1RA/IL-1α | Control | 0.49488 | 0.0434 | 17 |
| Itching and log Malassezia total (=globosa + restricta) | Control | 0.40976 | 0.0245 | 30 |
Only significant correlations are shown
PLK plakoglobin, IL interleukin, SGA subjective global assessment
* Spearman’s test